Click for best price
Targeted Small Molecule Therapy Market Size, Share 2023
Targeted therapy is?a type of cancer treatment that uses drugs or other substances to precisely identify and attack certain types of cancer cells. A targeted therapy can be used by itself or in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy.
This report aims to provide a comprehensive presentation of the global market for Targeted Small Molecule Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Small Molecule Therapy. This report contains market size and forecasts of Targeted Small Molecule Therapy in global, including the following market information:
Global Targeted Small Molecule Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Targeted Small Molecule Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Sorafenib Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Targeted Small Molecule Therapy include Bayer, Eisai, Zelgen, Cipla, Natco Pharma, AstraZeneca, Novartis, Roche and Bristol-Myers Squibb, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Targeted Small Molecule Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Targeted Small Molecule Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Targeted Small Molecule Therapy Market Segment Percentages, by Type, 2022 (%)
Sorafenib
Lenvatinib
Regorafenib
Osimertinib
Anlotinib
Alectinib
Other
Global Targeted Small Molecule Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Targeted Small Molecule Therapy Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Other
Global Targeted Small Molecule Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Targeted Small Molecule Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Targeted Small Molecule Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Targeted Small Molecule Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Eisai
Zelgen
Cipla
Natco Pharma
AstraZeneca
Novartis
Roche
Bristol-Myers Squibb
Pfizer
BEACON Pharma
Jiangxi Shanxiang
Yao Pharma
CSPC
CHIATAI Tianqing
Simcere
Outline of Major Chapters:
Chapter 1: Introduces the definition of Targeted Small Molecule Therapy, market overview.
Chapter 2: Global Targeted Small Molecule Therapy market size in revenue.
Chapter 3: Detailed analysis of Targeted Small Molecule Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Targeted Small Molecule Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Targeted Small Molecule Therapy Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
101 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Targeted Small Molecule Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Targeted Small Molecule Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Targeted Small Molecule Therapy Overall Market Size
2.1 Global Targeted Small Molecule Therapy Market Size: 2022 VS 2029
2.2 Global Targeted Small Molecule Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Targeted Small Molecule Therapy Players in Global Market
3.2 Top Global Targeted Small Molecule Therapy Companies Ranked by Revenue
3.3 Global Targeted Small Molecule Therapy Revenue by Companies
3.4 Top 3 and Top 5 Targeted Small Molecule Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Targeted Small Molecule Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Targeted Small Molecule Therapy Players in Global Market
3.6.1 List of Global Tier 1 Targeted Small Molecule Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Targeted Small Molecule Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Targeted Small Molecule Therapy Market Size Markets, 2022 & 2029
4.1.2 Sorafenib
4.1.3 Lenvatinib
4.1.4 Regorafenib
4.1.5 Osimertinib
4.1.6 Anlotinib
4.1.7 Alectinib
4.1.8 Other
4.2 By Type - Global Targeted Small Molecule Therapy Revenue & Forecasts
4.2.1 By Type - Global Targeted Small Molecule Therapy Revenue, 2018-2023
4.2.2 By Type - Global Targeted Small Molecule Therapy Revenue, 2024-2029
4.2.3 By Type - Global Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Targeted Small Molecule Therapy Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Targeted Small Molecule Therapy Revenue & Forecasts
5.2.1 By Application - Global Targeted Small Molecule Therapy Revenue, 2018-2023
5.2.2 By Application - Global Targeted Small Molecule Therapy Revenue, 2024-2029
5.2.3 By Application - Global Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Targeted Small Molecule Therapy Market Size, 2022 & 2029
6.2 By Region - Global Targeted Small Molecule Therapy Revenue & Forecasts
6.2.1 By Region - Global Targeted Small Molecule Therapy Revenue, 2018-2023
6.2.2 By Region - Global Targeted Small Molecule Therapy Revenue, 2024-2029
6.2.3 By Region - Global Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Targeted Small Molecule Therapy Revenue, 2018-2029
6.3.2 US Targeted Small Molecule Therapy Market Size, 2018-2029
6.3.3 Canada Targeted Small Molecule Therapy Market Size, 2018-2029
6.3.4 Mexico Targeted Small Molecule Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Targeted Small Molecule Therapy Revenue, 2018-2029
6.4.2 Germany Targeted Small Molecule Therapy Market Size, 2018-2029
6.4.3 France Targeted Small Molecule Therapy Market Size, 2018-2029
6.4.4 U.K. Targeted Small Molecule Therapy Market Size, 2018-2029
6.4.5 Italy Targeted Small Molecule Therapy Market Size, 2018-2029
6.4.6 Russia Targeted Small Molecule Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Targeted Small Molecule Therapy Market Size, 2018-2029
6.4.8 Benelux Targeted Small Molecule Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Targeted Small Molecule Therapy Revenue, 2018-2029
6.5.2 China Targeted Small Molecule Therapy Market Size, 2018-2029
6.5.3 Japan Targeted Small Molecule Therapy Market Size, 2018-2029
6.5.4 South Korea Targeted Small Molecule Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Targeted Small Molecule Therapy Market Size, 2018-2029
6.5.6 India Targeted Small Molecule Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Targeted Small Molecule Therapy Revenue, 2018-2029
6.6.2 Brazil Targeted Small Molecule Therapy Market Size, 2018-2029
6.6.3 Argentina Targeted Small Molecule Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Targeted Small Molecule Therapy Revenue, 2018-2029
6.7.2 Turkey Targeted Small Molecule Therapy Market Size, 2018-2029
6.7.3 Israel Targeted Small Molecule Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Targeted Small Molecule Therapy Market Size, 2018-2029
6.7.5 UAE Targeted Small Molecule Therapy Market Size, 2018-2029
7 Targeted Small Molecule Therapy Companies Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Targeted Small Molecule Therapy Major Product Offerings
7.1.4 Bayer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 Eisai
7.2.1 Eisai Company Summary
7.2.2 Eisai Business Overview
7.2.3 Eisai Targeted Small Molecule Therapy Major Product Offerings
7.2.4 Eisai Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.2.5 Eisai Key News & Latest Developments
7.3 Zelgen
7.3.1 Zelgen Company Summary
7.3.2 Zelgen Business Overview
7.3.3 Zelgen Targeted Small Molecule Therapy Major Product Offerings
7.3.4 Zelgen Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.3.5 Zelgen Key News & Latest Developments
7.4 Cipla
7.4.1 Cipla Company Summary
7.4.2 Cipla Business Overview
7.4.3 Cipla Targeted Small Molecule Therapy Major Product Offerings
7.4.4 Cipla Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.4.5 Cipla Key News & Latest Developments
7.5 Natco Pharma
7.5.1 Natco Pharma Company Summary
7.5.2 Natco Pharma Business Overview
7.5.3 Natco Pharma Targeted Small Molecule Therapy Major Product Offerings
7.5.4 Natco Pharma Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.5.5 Natco Pharma Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Targeted Small Molecule Therapy Major Product Offerings
7.6.4 AstraZeneca Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Targeted Small Molecule Therapy Major Product Offerings
7.7.4 Novartis Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 Roche
7.8.1 Roche Company Summary
7.8.2 Roche Business Overview
7.8.3 Roche Targeted Small Molecule Therapy Major Product Offerings
7.8.4 Roche Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.8.5 Roche Key News & Latest Developments
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Company Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Targeted Small Molecule Therapy Major Product Offerings
7.9.4 Bristol-Myers Squibb Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.9.5 Bristol-Myers Squibb Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Targeted Small Molecule Therapy Major Product Offerings
7.10.4 Pfizer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.10.5 Pfizer Key News & Latest Developments
7.11 BEACON Pharma
7.11.1 BEACON Pharma Company Summary
7.11.2 BEACON Pharma Business Overview
7.11.3 BEACON Pharma Targeted Small Molecule Therapy Major Product Offerings
7.11.4 BEACON Pharma Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.11.5 BEACON Pharma Key News & Latest Developments
7.12 Jiangxi Shanxiang
7.12.1 Jiangxi Shanxiang Company Summary
7.12.2 Jiangxi Shanxiang Business Overview
7.12.3 Jiangxi Shanxiang Targeted Small Molecule Therapy Major Product Offerings
7.12.4 Jiangxi Shanxiang Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.12.5 Jiangxi Shanxiang Key News & Latest Developments
7.13 Yao Pharma
7.13.1 Yao Pharma Company Summary
7.13.2 Yao Pharma Business Overview
7.13.3 Yao Pharma Targeted Small Molecule Therapy Major Product Offerings
7.13.4 Yao Pharma Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.13.5 Yao Pharma Key News & Latest Developments
7.14 CSPC
7.14.1 CSPC Company Summary
7.14.2 CSPC Business Overview
7.14.3 CSPC Targeted Small Molecule Therapy Major Product Offerings
7.14.4 CSPC Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.14.5 CSPC Key News & Latest Developments
7.15 CHIATAI Tianqing
7.15.1 CHIATAI Tianqing Company Summary
7.15.2 CHIATAI Tianqing Business Overview
7.15.3 CHIATAI Tianqing Targeted Small Molecule Therapy Major Product Offerings
7.15.4 CHIATAI Tianqing Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.15.5 CHIATAI Tianqing Key News & Latest Developments
7.16 Simcere
7.16.1 Simcere Company Summary
7.16.2 Simcere Business Overview
7.16.3 Simcere Targeted Small Molecule Therapy Major Product Offerings
7.16.4 Simcere Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.16.5 Simcere Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Targeted Small Molecule Therapy Market Opportunities & Trends in Global Market
Table 2. Targeted Small Molecule Therapy Market Drivers in Global Market
Table 3. Targeted Small Molecule Therapy Market Restraints in Global Market
Table 4. Key Players of Targeted Small Molecule Therapy in Global Market
Table 5. Top Targeted Small Molecule Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Targeted Small Molecule Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Targeted Small Molecule Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Targeted Small Molecule Therapy Product Type
Table 9. List of Global Tier 1 Targeted Small Molecule Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Targeted Small Molecule Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Targeted Small Molecule Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Targeted Small Molecule Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Targeted Small Molecule Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Targeted Small Molecule Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Targeted Small Molecule Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Targeted Small Molecule Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Targeted Small Molecule Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Targeted Small Molecule Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Targeted Small Molecule Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Targeted Small Molecule Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Targeted Small Molecule Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Targeted Small Molecule Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Targeted Small Molecule Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Targeted Small Molecule Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Bayer Company Summary
Table 31. Bayer Targeted Small Molecule Therapy Product Offerings
Table 32. Bayer Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Bayer Key News & Latest Developments
Table 34. Eisai Company Summary
Table 35. Eisai Targeted Small Molecule Therapy Product Offerings
Table 36. Eisai Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Eisai Key News & Latest Developments
Table 38. Zelgen Company Summary
Table 39. Zelgen Targeted Small Molecule Therapy Product Offerings
Table 40. Zelgen Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Zelgen Key News & Latest Developments
Table 42. Cipla Company Summary
Table 43. Cipla Targeted Small Molecule Therapy Product Offerings
Table 44. Cipla Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Cipla Key News & Latest Developments
Table 46. Natco Pharma Company Summary
Table 47. Natco Pharma Targeted Small Molecule Therapy Product Offerings
Table 48. Natco Pharma Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Natco Pharma Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Targeted Small Molecule Therapy Product Offerings
Table 52. AstraZeneca Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Targeted Small Molecule Therapy Product Offerings
Table 56. Novartis Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Novartis Key News & Latest Developments
Table 58. Roche Company Summary
Table 59. Roche Targeted Small Molecule Therapy Product Offerings
Table 60. Roche Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Roche Key News & Latest Developments
Table 62. Bristol-Myers Squibb Company Summary
Table 63. Bristol-Myers Squibb Targeted Small Molecule Therapy Product Offerings
Table 64. Bristol-Myers Squibb Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Bristol-Myers Squibb Key News & Latest Developments
Table 66. Pfizer Company Summary
Table 67. Pfizer Targeted Small Molecule Therapy Product Offerings
Table 68. Pfizer Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Pfizer Key News & Latest Developments
Table 70. BEACON Pharma Company Summary
Table 71. BEACON Pharma Targeted Small Molecule Therapy Product Offerings
Table 72. BEACON Pharma Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. BEACON Pharma Key News & Latest Developments
Table 74. Jiangxi Shanxiang Company Summary
Table 75. Jiangxi Shanxiang Targeted Small Molecule Therapy Product Offerings
Table 76. Jiangxi Shanxiang Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Jiangxi Shanxiang Key News & Latest Developments
Table 78. Yao Pharma Company Summary
Table 79. Yao Pharma Targeted Small Molecule Therapy Product Offerings
Table 80. Yao Pharma Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. Yao Pharma Key News & Latest Developments
Table 82. CSPC Company Summary
Table 83. CSPC Targeted Small Molecule Therapy Product Offerings
Table 84. CSPC Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. CSPC Key News & Latest Developments
Table 86. CHIATAI Tianqing Company Summary
Table 87. CHIATAI Tianqing Targeted Small Molecule Therapy Product Offerings
Table 88. CHIATAI Tianqing Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 89. CHIATAI Tianqing Key News & Latest Developments
Table 90. Simcere Company Summary
Table 91. Simcere Targeted Small Molecule Therapy Product Offerings
Table 92. Simcere Targeted Small Molecule Therapy Revenue (US$, Mn) & (2018-2023)
Table 93. Simcere Key News & Latest Developments
List of Figures
Figure 1. Targeted Small Molecule Therapy Segment by Type in 2022
Figure 2. Targeted Small Molecule Therapy Segment by Application in 2022
Figure 3. Global Targeted Small Molecule Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Targeted Small Molecule Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Targeted Small Molecule Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Targeted Small Molecule Therapy Revenue in 2022
Figure 8. By Type - Global Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Targeted Small Molecule Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Targeted Small Molecule Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
Figure 16. US Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
Figure 28. China Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Targeted Small Molecule Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Bayer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Eisai Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Zelgen Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Cipla Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Natco Pharma Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AstraZeneca Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novartis Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Roche Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bristol-Myers Squibb Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Pfizer Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. BEACON Pharma Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Jiangxi Shanxiang Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Yao Pharma Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. CSPC Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. CHIATAI Tianqing Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Simcere Targeted Small Molecule Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
